Reset
Showing 20 of 61 academic articles

Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers

Meng Zhang, Ping He, Zhigang Bian • Frontiers in Molecular Neuroscience (2021)

Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are progressive and ultimately fatal. NDD onset is influenced by several fa...

DOAJ Open Access (DOAJ) DOI: 10.3389/fnmol.2021.685143

Nanotechnology and its Applications in Medicine

Anna Pratima Nikalje • Medicinal Chemistry (2015)

Nanotechnologyis the study of extremely small structures, having size of 0.1 to 100 nm. Nano medicine is a relatively new field of science and technology. Brief explanation of various types of pharmaceutical nano systems is given. Classific...

OPENALEX DOI: https://doi.org/10.4172/2161-0444.1000247

Graphene Oxide and Reduced Derivatives, as Powder or Film Scaffolds, Differentially Promote Dopaminergic Neuron Differentiation and Survival

Noela Rodriguez-Losada, Noela Rodriguez-Losada, Rune Wendelbob, M. Carmen Ocaña et al. • Frontiers in Neuroscience (2020)

Emerging scaffold structures made of carbon nanomaterials, such as graphene oxide (GO) have shown efficient bioconjugation with common biomolecules. Previous studies described that GO promotes the differentiation of neural stem cells and ma...

DOAJ Open Access (DOAJ) DOI: 10.3389/fnins.2020.570409

Membrane Dysfunction as a Central Mechanism in LRRK2-Associated Parkinson’s Disease: Comparative Analysis of G2019S and I1371V Variants

Khushboo Singh, Roon Banerjee, Chandrakanta Potdar, Anisha Shaw et al. • Cells (2026)

Mutations in leucine-rich repeat kinase 2 (LRRK2) are among the most common genetic causes of Parkinson’s disease (PD), yet substantial heterogeneity exists among pathogenic variants. How mutations in distinct functional domains of LRRK2 di...

DOAJ Open Access (DOAJ) DOI: 10.3390/cells15040342

Long-Term Prognosis and Systemic Impact of Acromegaly: Analyses Utilizing Korean National Health Insurance Data

Sangmo Hong, Kyungdo Han, Cheol-Young Park • Endocrinology and Metabolism (2025)

Acromegaly is a rare endocrine disorder caused by excessive growth hormone secretion. Its low prevalence poses challenges in studying its long-term prognosis and systemic effects. To address this research gap, we conducted five studies usin...

DOAJ Open Access (DOAJ) DOI: 10.3803/EnM.2024.2285

Ranking of treatments in network meta-analysis: incorporating minimally important differences

Tristan Curteis, Augustine Wigle, Christopher J. Michaels, Adriani Nikolakopoulou • BMC Medical Research Methodology (2025)

Abstract Background In network meta-analysis (NMA), the magnitude of difference between treatment effects is typically ignored in the calculation of ranking metrics, such as probability best and surface under the cumulative ranking curve (S...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12874-025-02499-0

Effet de l'illumination proche infra-rouge intracérébrale chez des primates MPTP

Fannie Darlot, Cécile Moro, Napoléon Torres‑Martinez, Claude Chabrol et al. • Revue de Primatologie (2015)

La maladie de Parkinson (MP) est une maladie neurodégénérative chronique affectant le système dopaminergique et se traduisant par une perte des neurones dopaminergiques (DA) de la substance noire compacta (SNc) et des faisceaux nigro-striés...

DOAJ Open Access (DOAJ) DOI: 10.4000/primatologie.2073

Elements of Nuclear Engineering

Thomas F. Parkinson • Nuclear Science and Engineering (1961)

"Elements of Nuclear Engineering." Nuclear Science and Engineering, 11(2), pp. 232–233 Additional informationNotes on contributorsT. F. Parkinson(Editor’s Note: Tom Parkinson was with Savannah River Laboratory for eight years immediately fo...

OPENALEX DOI: https://doi.org/10.13182/nse61-a28074

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease

Stewart F. Graham, Nolwen L. Rey, Zafer Ugur, Ali Yilmaz et al. • Metabolites (2018)

For people with Parkinson’s disease (PD), considered the most common neurodegenerative disease behind Alzheimer’s disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodrom...

DOAJ Open Access (DOAJ) DOI: 10.3390/metabo8040071

De novo SCN1A missense variant in a patient with Parkinson’s disease

Majed Alluqmani, Abdulfatah M. Alayoubi, Jamil A. Hashmi, Jamil A. Hashmi et al. • Frontiers in Genetics (2024)

BackgroundVariants in a gene encoding sodium voltage-gated channel alpha subunit 1 (SCN1A) are known to cause a broad clinical spectrum of epilepsy and associated features, including Dravet syndrome (MIM 607208), non-Dravet developmental an...

DOAJ Open Access (DOAJ) DOI: 10.3389/fgene.2024.1496683

Neurotoxicity of PM<sub>2.5</sub>-Bound Multi-Pollutant Mixtures in Parkinson’s Disease: Exploring the <i>INPP5D</i>/SHIP1-PI3K-AKT Axis via an Integrative Multi-Omics Study

Lufei Chen, Chaoxian Dai, Zhenfang Wu, Yuhan Lin et al. • Journal of Xenobiotics (2026)

Accumulating epidemiological evidence links ambient PM2.5 exposure to elevated Parkinson’s disease (PD) risk, yet the neurotoxicity triggered by PM2.5 multi-pollutant mixtures under real co-exposure scenarios remains insufficiently elucidat...

DOAJ Open Access (DOAJ) DOI: 10.3390/jox16060184

The effect of structured medication review followed by face-to-face feedback to prescribers on adverse drug events recognition and prevention in older inpatients – a multicenter interrupted time series study

Joanna E. Klopotowska, Paul F. M. Kuks, Peter C. Wierenga, Clementine C. M. Stuijt et al. • BMC Geriatrics (2022)

Abstract Background The effectiveness of interventions to improve medication safety in older inpatients is unclear, given a paucity of properly designed intervention studies applying clinically relevant endpoints such as hospital-acquired p...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12877-022-03118-z

Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials

Emma A. Honkanen, Mikael Eklund, Simo Nuuttila, Tommi Noponen et al. • NeuroImage: Clinical (2021)

Objective: To evaluate possible differences between brain dopamine transporter (DAT) binding in a group of symptomatic parkinsonism patients without dopaminergic degeneration and healthy individuals. Background: Dopaminergic neuroimaging st...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.nicl.2021.102807